Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial

Ji, Linong; Tong, Xiaolin; Wang, Hongyuan; Tian, Haoming; Zhou, Huimin; Zhang, Lili; Li, Qifu; Wang, Yizhong; Li, Hongmei; Liu, Min; Yang, Hongjie; Gao, Yanbin; Li, Yan; Li, Quanmin; Guo, Xiaohui; Yang, Gangyi; Zhang, Zhongai; Zhou, Zhiguang; Ning, Guang; Chen, Yingli
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Treatment of diabetes mellitus with Traditional Chinese Medicine has a long history. The aim of this study is to establish the safety and efficacy of traditional Chinese medicine combined with glibenclamide to treat type 2 diabetes mellitus. Methods: In a controlled, double blind, multicentre non-inferiority trial, 800 patients with unsatisfactory glycemic control (fasting glucose 7–13 mmol/L and HbA1c 7–11%) were randomly assigned to receive Xiaoke Pill, a compound of Chinese herbs combined with glibenclamide, or Glibenclamide in two study groups – drug naive group, and patients previously treated with metformin monotherapy (metformin group). Outcome measures at 48 weeks were the incidence and rate of hypoglycemia, mean difference in HbA1c, and proportion of patients with HbA1c<6.5%. Findings: In drug naïve group, the total hypoglycemia rate and the mild hypoglycemic episode in the Xiaoke Pill arm were 38% (p = 0.024) and 41% (p = 0.002) less compared to Glibenclamide arm; in Metformin group, the average annual rate of hypoglycemia was 62% lower in Xiaoke Pill arm (p = 0.003). Respective mean changes in HbA1c from baseline were −0.70% and −0.66% for Xiaoke Pill and Glibenclamide, with a between-group difference (95% CI) of −0.04% (−0.20, 0.12) in the drug naïve group, and those in metformin group were −0.45% and −0.59%, 0.14% (−0.12, 0.39) respectively. The respective proportions of patients with a HbA1c level <6.5% were 26.6% and 23.4% in the drug naïve group and 20.1% and 18.9% in the metformin group. Interpretation: In patients with type 2 diabetes and inadequate glycaemic control, treatment with Xiaoke Pill led to significant reduction in risk of hypoglycemia and similar improvements in glycemic control after 48 weeks compared to Glibenclamide. Trial Registration: Chinese Clinical Trial Register number, ChiCTR-TRC-08000074


Related Articles

  • Chinese Herbal Medicine for Diabetic Peripheral Neuropathy: An Updated Meta-Analysis of 10 High-Quality Randomized Controlled Studies. Hao, Chi-zi; Wu, Fan; Lu, Lin; Wang, Juan; Guo, Yi; Liu, Ai-ju; Liao, Wei-jing; Zheng, Guo-qing // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: Diabetic peripheral neuropathy (DPN) is very common in people with diabetes. Chinese herbal medicine (CHM) therapy has been developed for DPN empirically over the years. The aim of this systematic review and meta-analysis was to assess the efficacy and safety of CHMs for patients...

  • A Double-Blind, Randomised, Crossover Trial of Two Botulinum Toxin Type A in Patients with Spasticity. Guarany, Fábio Coelho; Picon, Paulo Dornelles; Guarany, Nicole Ruas; dos Santos, Antonio Cardoso; Chiella, Bianca Paula Mentz; Barone, Carolina Rocha; Fendt, Lúcia Costa Cabral; Schestatsky, Pedro // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these...

  • Review: Meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p65 

    The article offers information on a study investigating the effectiveness of meglitinide analogues (MAs) for patients with type 2 diabetes mellitus (DM). It describes the procedure and randomized controlled trials (RCTs), that were conducted during the study. The study revealed that MAs reduce...

  • Reversal of Muscle Atrophy by Zhimu-Huangbai Herb-Pair via Akt/mTOR/FoxO3 Signal Pathway in Streptozotocin-Induced Diabetic Mice. Zhang, Jinbao; Zhuang, Pengwei; Wang, Yan; Song, Lili; Zhang, Mixia; Lu, Zhiqiang; Zhang, Lu; Wang, Jing; Alemu, Paulos N.; Zhang, Yanjun; Wei, Hongjun; Li, Hongyan // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Skeletal muscle atrophy is one of the serious complications of diabetes. Zhimu-Huangbai herb-pair (ZB) is widely used in Chinese traditional medicine formulas for treating Xiaoke (known as diabetes) and its complications. However, the effect of ZB on reversal of muscle atrophy and the underlying...

  • Complementary Efforts Make for Efficient Research. Selby, Joseph V. // Annals of Internal Medicine;6/7/2016, Vol. 164 Issue 11, p771 

    The article discusses the contradictory discussions of randomized and observational studies of effectiveness or safety of drugs.

  • Wnt signalling sees spots. Povelones, Michael; Nusse, Roel // Nature Cell Biology;Nov2002, Vol. 4 Issue 11, pE249 

    The organization of signalling complexes represents the coalescence of cell biology and signal transduction. Recent work on Dishevelled (Dvl), a multifunctional component of the Wnt-Frizzled (Fz) signalling pathway, ascribes vesicle- and actin-binding properties to a single domain within the...

  • Alliance for cellular signaling: Into unknown territory. Abbott, Alison // Nature;12/12/2002, Vol. 420 Issue 6916, p600 

    Focuses on Alliance for Cellular Signaling's aim to explore the way in which research in cell biology is conducted. Plan to collate existing information about components of signaling pathways; Generation of robust data about pathways into two types of mouse cell; Development of the Molecule...

  • The Interplays between Autophagy and Apoptosis Induced by Enterovirus 71. Xi, Xueyan; Zhang, Xiaoyan; Wang, Bei; Wang, Tao; Wang, Ji; Huang, He; Wang, Jianwei; Jin, Qi; Zhao, Zhendong // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Enterovirus 71 (EV71) is the causative agent of human diseases with distinct severity, from mild hand, foot and mouth disease to severe neurological syndromes, such as encephalitis and meningitis. The lack of understanding of viral pathogenesis as well as lack of efficient vaccine...

  • DBZ Blocks LPS-induced Monocyte Activation and Foam Cell Formation via Inhibiting Nuclear Factor-κB. Xie, Xinni; Wang, Shixiang; Xiao, Lei; Zhang, Jun; Wang, Jing; Liu, Jin; Shen, Xuji; He, Dacheng; Zheng, Xiaohui; Zhai, Yonggong // Cellular Physiology & Biochemistry (Karger AG);2011, Vol. 28 Issue 4, p649 

    Background/Aims: It has been widely accepted that chronic inflammation plays important roles in the atherogenesis. Danshensu Bingpian Zhi (DBZ) is a novel synthetic compound derived from the traditional Chinese medicine (TCM) formula Fu Fang Dan Shen (FFDS), which is effective on atherosclerosis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics